UNLOCK

How many AI events have you been to where you left with something you could actually use? That's the bar we set for UNLOCK. One day of keynotes and panels with people actually building. Not the people talking about it from the sidelines. https://unlockscience.ai

Conferences like to tell you everything is changing. Few of them will tell you what's actually working. Sponsored tickets available for a few more days. Apply now to learn directly from the people bringing AI to biology every day. https://unlockscience.ai

Carina Hong is joining UNLOCK 2026. Most AI guesses at answers. Carina's company Axiom builds AI that can mathematically prove it's right. Their system outperformed all ~4,000 human contestants in one of math's hardest competitions. Axiom raised $200M at a $1.6B valuation to bring this kind of provable reasoning into high-stakes fields like drug discovery. Carina is 24. Morgan Prize winner, Rhodes Scholar, Stanford PhD dropout. Her team comes from Meta FAIR and Google Brain. Hear how she does it at UNLOCK. April 22. San Francisco. https://unlockscience.ai

Andrew White is joining UNLOCK 2026. His team built Kosmos, an AI that can do scientific research on its own. You give it a dataset and a question, and it reads papers, runs analyses, forms hypotheses, and writes up what it finds with full citations, within 12 hours. Work that normally takes a researcher months. 30,000 researchers have already used it and Edison Scientific raised $70M to keep building. Andrew previously built ChemCrow, the first AI agent for chemistry. That one got him called into a White House briefing. April 22. San Francisco. https://unlockscience.ai

A limited number of Sponsored Tickets to UNLOCK are now available! Thanks to generous support from a group of investors, a limited number of subsidized tickets for qualified attendees are now available! A more accessible way to hear directly from Nobel Laureates, leaders in pharma, CEOs and Founders of the hottest AI x Science startups, and more. Qualify at https://unlockscience.ai

Jacob Kimmel is joining UNLOCK 2026. As cells age, they start to malfunction. Jacob, CEO and Co-founder of NewLimit, is using AI to figure out exactly what changes in a cell as it gets older, and then reverse those changes. The goal is to reprogram aging itself. One of the most ambitious bets in biotech right now. And you can hear about it at UNLOCK. April 22. San Francisco. Register 👉 https://unlockscience.ai

Peyton Greenside is joining UNLOCK 2026. BigHat Biosciences designs antibodies, the proteins used in many of today's most important drugs. Their AI predicts which designs will work, their lab builds and tests them, and then the results go back into the AI to make it smarter. That full loop, prediction to lab to learning, is what sets them apart. Peyton co-founded and leads BigHat. Before that, she studied how genes are regulated at Stanford using machine learning. Hear it from her. April 22. San Francisco. unlockscience.ai

Jonah Cool is joining UNLOCK 2026. Jonah leads life sciences at Anthropic. His focus is on where AI like Claude is actually useful in biology and drug discovery today, and where it's going. Before Anthropic, he was at the Chan Zuckerberg Initiative, where he ran programs supporting open science and biomedical research tools. April 22. San Francisco. https://unlockscience.ai

Anna Marie Wagner is joining UNLOCK 2026. A lot of what scientists learn in the lab gets buried in notes, lost in handoffs, or stuck in one person's head. Transfyr is working on fixing that. Anna Marie is Co-Founder and CEO at Transfyr, where she's building AI-powered infrastructure to make scientific knowledge more transferable and reproducible. Hear it from her directly at UNLOCK. April 22. San Francisco. unlockscience.ai

Martin Borch Jensen is joining UNLOCK 2026. Most drug discovery for age-related diseases starts in a plastic dish with young cells. That's a problem. Martin is Co-Founder and CSO at Gordian Biotechnology, where his team built a platform that tests hundreds of gene therapies simultaneously in living animals that actually resemble aging human patients. They use AI to analyze the results across entire cellular pathways and predict which targets will translate to real clinical outcomes. It's a fundamentally different approach to finding treatments for diseases like heart failure, pulmonary fibrosis, and osteoarthritis. April 22. San Francisco. unlockscience.ai